In October 2024, Pharmac introduced funded diabetes technology for people living with type 1 diabetes. Most people who choose to use this technology are now established on CGM, and more than 60 per cent are using insulin pumps or automated insulin delivery systems.
As more of these patients begin requesting prescriptions for pump and CGM consumables through primary care, we’ve created this guide to support you with the prescribing process. If you need further assistance, please reach out to your regional diabetes lead:
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreThe Diabetes and Chronic Kidney Disease program aims to slow progression of CKD leading to end-stage renal disease and other diabetes related complications. The aims are achieved by partnering with the patient/whanau, sharing matauranga/knowledge, improving self-management skills and strategies, and enabling appropriate treatment intensification. For people living with suboptimal diabetes (Hbalc greater than 53 mmol/mol) and CKD 3B or earlier (eGFR 30 ml/min and above), please see the referral criteria and pathway for guidance.
Read moreFunding for patients who require a follow-up appointment following HbA1c retest by Awanui Labs.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.